Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04660331 · ClinicalTrials.gov registry record · NA
Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT04660331 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 42 participants.
The verdict
NCT04660331, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This trial investigates how a communication strategy works in increasing human papillomavirus (HPV) vaccines in community pharmacies among adolescents. Although pharmacies are vaccine providers, low vaccination rates are persistent as a result of low awareness of pharmacy services and poor engagement by pharmacy staff with adolescents about vaccines. The purpose of this study is to test a communication strategy that identifies vaccine-eligible children and teaches pharmacy staff how to effectively communicate with them about HPV vaccination in order to increase HPV vaccination rates.
Interventions
- OTHER Survey Administration
- OTHER Communication Intervention
- BEHAVIORAL Healthcare Activity
- OTHER Communication Skills Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04660331
The ClinicalTrials.gov registry entry for NCT04660331 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.
NCT04660331 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04660331 about?
NCT04660331 is a clinical study titled "Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study". This trial investigates how a communication strategy works in increasing human papillomavirus (HPV) vaccines in community pharmacies among adolescents. Although pharmacies are vaccine providers, low vaccination rates are persistent as a result of low awareness of pharmacy services and poor engagemen...
What is the current status of trial NCT04660331?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-02-01. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04660331?
The interventions under investigation include: Survey Administration (OTHER), Communication Intervention (OTHER), Healthcare Activity (BEHAVIORAL), Communication Skills Training (OTHER).
Who is sponsoring clinical trial NCT04660331?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.